| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.82M | $ 1.73M | $ 1.30M | $ 349.14K |
| Gross Profit | $ 0.00 | $ 1.76M | $ 1.67M | $ 1.23M | $ 339.50K |
| Operating Income | $ -2.73M | $ -4.27M | $ -3.62M | $ -18.26M | $ -709.00K |
| EBITDA | $ -2.02M | $ -7.68M | $ -3.37M | $ -17.80M | $ -3.08M |
| Net Income | $ 1.27M | $ -7.94M | $ -3.65M | $ -18.06M | $ -3.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.62K | $ 113.49K | $ 157.59K | $ 301.34K | $ 433.44K |
| Total Assets | $ 250.41K | $ 651.88K | $ 4.45M | $ 4.80M | $ 5.24M |
| Total Debt | $ 649.21K | $ 2.19M | $ 2.18M | $ 2.34M | $ 2.24M |
| Net Debt | $ 635.59K | $ 2.08M | $ 2.02M | $ 2.04M | $ 1.81M |
| Total Liabilities | $ 1.30M | $ 6.13M | $ 5.76M | $ 6.21M | $ 5.30M |
| Stockholders' Equity | $ -1.05M | $ -5.48M | $ -1.31M | $ -1.41M | $ -55.45K |
| Cash Flow | |||||
| Free Cash Flow | $ 3.08M | $ -233.80K | $ -181.56K | $ -629.24K | $ 28.10K |
| Operating Cash Flow | $ 3.08M | $ -183.13K | $ -168.97K | $ -582.88K | $ 28.10K |
| Investing Cash Flow | $ -127.50K | $ -50.67K | $ 5.40K | $ -10.20K | $ -1.56M |
| Financing Cash Flow | $ 352.97K | $ 189.70K | $ 19.82K | $ 460.98K | $ 1.97M |
Innovative Medtech Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.